Sign Up Today and Learn More About Orbital Therapeutics Stock
Invest in or calculate the value of your shares in Orbital Therapeutics or other pre-IPO companies through EquityZen's platform.
Orbital Therapeutics Stock (ORTH)
Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.
About Orbital Therapeutics Stock
Founded
2022
Headquarters
Cambridge, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Orbital Therapeutics Press Mentions
Stay in the know about the latest news on Orbital Therapeutics
Orbital Therapeutics Appoints Veteran Biopharma Leader, Ron Philip, as Chief Executive Officer
businesswire • Sep 03, 2024
Orbital Therapeutics on LinkedIn: #optboston #mrnatherapeutics
linkedin • Jun 04, 2024
Novo Nordisk inks Waltham lease, one of largest in life ...
bizjournals • Jan 19, 2024
The New Antibodies Revolutionizing Medicine :: In Vivo
invivo • Jan 19, 2024
Biotech entrepreneur Greg Verdine joins Andreessen ...
bizjournals • Dec 22, 2023
Orbital Therapeutics Management
Leadership team at Orbital Therapeutics
Board Member
Kristina Burow
Chief Financial Officer
Jonathan Piazza
Join now and verify your accreditation status to gain access to:
- Orbital Therapeutics current valuation
- Orbital Therapeutics stock price
- Available deals in Orbital Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Orbital Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Orbital Therapeutics through EquityZen funds. These investments are made available by existing Orbital Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Orbital Therapeutics stock?
Shareholders can sell their Orbital Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
